Welcome, Guest
Contact us  |   Careers  |  Open an Account  |  Site Map  |   Login    

Market

Mutual Fund
 You are in Top performing Funds/Schemes
News View Snapshot Top performing Funds/Schemes New Funds in lime light FII Investment Knowledge Center
Here are the details of the schemes you searched for  Franklin Pharma Fund - (G)

  Scheme Details
 
Asset Size (Cr.) Fund Mngr Launch Date Min. Inv Inc. Inv(Rs.)
142.24 Anand Radhakrishnan Mar 15 1999 5000 1000
  Latest Navs
 
Latest NAV Latest Dividend
65.5147 0.00
  1 Year NAV Chart
 
Chart.

  Previous NAV
 
Date NAV (Rs.)
31 Dec 2010 65.5147
30 Dec 2010 65.1937
29 Dec 2010 64.8279
28 Dec 2010 64.5794
27 Dec 2010 64.4127
more..
  Asset Allocation
 
Type AssetValue
Equity 93.20
Debt 0.00
Others 6.80
  Return Summary
 

Scheme Name 3MONTH 6MONTH 1YEAR
Franklin Pharma Fund - (G) 7.43 11.38 35.97
Nifty 1.19 14.86 18.04
Sensex 1.59 15.19 17.56
  Sectorial Allocation
 

Sector Assests(%) Value(Rs./Cr.)
Pharma 94.63 39.92
Others 5.37 2.26
  Previous Dividend
 
No data available
  Scheme Portfolio
 
Company %ofInv Inv Amt
Net CA & Others 12.452 17.7114
Cadila Health. 9.1239 12.9775
Dr Reddy's Labs 8.9744 12.7649
Torrent Pharma. 6.6052 9.3951
Ipca Labs. 6.1703 8.7765
more..
  Contact Information
 
Address Phone Fax Website
Level 4, Wockhardt Towers,Bandra Kurla Complex,Bandra (East). Mumbai - 400051. 022 - 67519100 022-66490622/66490627 www.franklintempletonindia.com

Company Search

New Trading Platforms

  Insta Plus
  View Insta Plus Demo

Terms & Conditions |  Disclaimer |  Online Privacy |  Trouble Logging in  |  Glossary |  Sitemap
Copyright©2010. All rights Reserved.
Equities: Equities transactions executed by Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 |BSE SEBI Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 | Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances/complaints please write to us at: grievance@rsec.co.in
This site is best viewed in 1024x768 and higher resolution.